A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia

por Lévy, V, Zohar, S, Bardin, C, Vekhoff, A, Chaoui, D, Rio, B, Legrand, O, Sentenac, S, Rousselot, P, Raffoux, E, Chast, F, Chevret, S, Marie, J P
Publicado 2006